US filing analysis
Sorted by SEC acceptance time (filing date when unavailable). Page 8 · 30 shown · up to 30 per page
TMO
The company said Michael D. Shafer, its Executive Vice President, will retire effective December 31, 2026, announced on October 27, 2026.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Thermo Fisher ScientificTMO$669.54-2.79%
ALB
The company said it entered into a credit agreement with JPMorgan Chase Bank, N.A. as administrative agent on October 29, 2026, the 2026 Credit Agreement, an unsecured revolving credit facility of up to $1.5 billion, maturing on October 29, 2031.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
AlbemarleALB$79.7-3.89%
ILMN
Illumina said YTD 2026 revenue rose 6% from $3,184 million a year earlier to $3,380 million, and operating margin was 22.5% (19.0% in YTD 2025). The company cited higher consumables and instruments revenue tied to demand for its NovaSeq X instrument as the driver of the revenue increase.
US filing analysisUS10-Q · Quarterly reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
IlluminaILMN$193.11-3.76%
DASH
DoorDash said Total Orders for Q3 2026 rose to 993 million, up 28% from the same quarter a year earlier, and Marketplace GOV rose 36% to $33.9 billion. The company cited growth in the number of consumers and the acquisition of Deliveroo plc as the drivers of the Total Orders increase.
US filing analysisUS10-Q · Quarterly reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
DoorDashDASH$152.75-2.79%
ACGL
The company said its subsidiary Arch Reinsurance Ltd. (ArchRe) entered into Amendment No. 6 to the Letter of Credit Facility Agreement with Lloyds Bank Corporate Markets plc as Administrative Agent and L/C Agent on October 28, 2026.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Arch Capital GroupACGL$108.87+0.66%
PLD
The company and Prologis, L.P. entered into an Equity Distribution Agreement on October 30, 2026 under which shares of common stock with a par value of $0.01 may be issued and sold from time to time in an at-the-market offering, with an aggregate offering price of up to $5,000,000,000.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
PrologisPLD$122.5-0.70%
ADP
The company said revenue for the 3 months ended September 30, 2026 rose 6% to $5,490.7 million, and grew 6% on an organic constant currency basis. It reported diluted EPS rose 14% to $2.83, and adjusted diluted EPS rose 13% to $2.82.
US filing analysisUS10-Q · Quarterly reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Automatic Data ProcessingADP$302.06+0.29%
AMP
Ameriprise said pretax income rose $253 million, or 22%, for the 3 months ended September 30, 2026 compared with the prior-year period. The company cited the favorable impact of higher average WEI, which rose 19%, and the cumulative effect of wrap net inflows as favorable factors. It cited the unfavorable impact of unlocking, which was $91 million, as an unfavorable factor.
US filing analysisUS10-Q · Quarterly reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Ameriprise FinancialAMP$480.29-2.45%
AXP
The company said it issued 5.447% Fixed-to-Floating Rate Notes due October 30, 2026 October 30, 2030 in an aggregate principal amount of $1,500,000,000.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
American ExpressAXP$301.7-3.02%
TER
The company said Semiconductor Test revenue for the quarter ended September 27, 2026 rose $466.1 million (76.9%), driven mainly by higher memory and compute sales tied to AI applications.
US filing analysisUS10-Q · Quarterly reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
TeradyneTER$204.86-9.92%
CHD
The company said net sales for the quarter ended September 30, 2026 rose $1,602.1, or $16.5 (1.0%), and diluted earnings per share were $0.89, up 18.7% from $0.75 in the same quarter of 2025.
US filing analysisUS10-Q · Quarterly reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Church & DwightCHD$110.84+1.06%
LYB
The company said its revenues for Q3 2026 fell $678 million (7%) from Q2, and operating income fell $476 million (31%). It cited lower average sales prices, which reduced revenue by 12%, and higher sales volumes, which added 6% to revenue, as the factors behind the change in revenue.
US filing analysisUS10-Q · Quarterly reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
LyondellBasellLYB$55.84-4.04%
D
The company said Dominion Energy net income attributable to the company rose 15% in Q3, citing higher rider equity returns at Virginia Power and the impacts of the 2025 Biennial Review. A decrease in net investment earnings on nuclear decommissioning trust funds partially offset these gains.
US filing analysisUS10-Q · Quarterly reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Dominion EnergyD$66.28-0.56%
LNT
The company said it plans to develop and/or acquire energy resources over the next 6 years to meet growing customer energy demand, including about 2,800 MW of new natural gas resources, about 1,300 MW of new energy storage and about 1,300 MW of new renewable generation.
US filing analysisUS10-Q · Quarterly reportPublished Oct 31, 2026 (UTC)SEC filing date Oct 30, 2026
Alliant EnergyLNT$71.62+0.31%
CTAS
Cintas said shareholders approved the proposal to reincorporate the company from Washington State to Delaware at its October 27, 2026 annual meeting, with 350,354,401 votes for, 520,454 against and 1,156,473 abstaining.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
CintasCTAS$220.03+0.51%
APO
Apollo said its subsidiary Athene Holding Ltd. made available a presentation titled “Athene's Role in Financing AI-Related Infrastructure” on its website at ir.athene.com.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Apollo Global ManagementAPO$111.16-4.41%
CBOE
Cboe said total revenues for the 3 months ended September 30, 2026 rose $217.1 million, or 19%, from the same period a year earlier. The company cited a change in Section 31 fee rates and higher derivatives market revenue from growth in trading volume on Cboe Options in April 2026 as the main drivers.
US filing analysisUS10-Q · Quarterly reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Cboe Global MarketsCBOE$357.75+0.02%
GD
The company reported third-quarter 2026 revenue of $14.6 billion, operating earnings of $1.5 billion, and diluted earnings per share of $4.49. Compared with the year-ago quarter, revenue rose 12.9%, operating earnings rose 14.7%, and diluted EPS rose 15.7%.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
General DynamicsGD$341.5-1.68%
CL
The company said net sales for Q3 rose 4.6% to $5,369 million, and organic sales grew 3.6%. Organic sales include a 0.2% negative impact from lower private label pet food sales.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Colgate-PalmoliveCL$98.71+1.89%
ABBV
AbbVie said worldwide net revenues for the Q3 2026 quarter were $17.404 billion, up 10.3% on a reported basis and 10.5% on an operational basis.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
AbbVieABBV$286.2+0.94%
FRT
The company said total property revenue for the 3 months ended September 30, 2026 rose $16.8 million (5.2%) to $339.0 million from $322.3 million a year earlier, and property operating income was $229.9 million. Occupancy was 93.8% at both dates.
US filing analysisUS10-Q · Quarterly reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Federal Realty Investment TrustFRT$110.27-0.14%
FRT
The company said net income available for common shareholders for Q3 2026 was $64.2 million ($0.74 per diluted share), and that Nareit FFO and Core FFO were each $163.0 million ($1.87 per diluted share). FFO for Q3 2025 was $153.0 million ($1.77 per share).
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Federal Realty Investment TrustFRT$110.27-0.14%
D
The company said GAAP net income for Q3 2026 (3 months) was $1.2 billion ($1.30 per diluted share), compared with $1.0 billion ($1.16 per share) for the same period in 2025.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Dominion EnergyD$66.28-0.56%
CBOE
The company said its net revenue (total revenues less cost of revenues) for Q3 2026 was $712.2 million, up 18% from $605.5 million in the same quarter of the prior year. Diluted earnings per share (EPS) was $4.08, up 43%, and adjusted diluted EPS was $3.63, up 36%.
US filing analysisUS8-K · Current reportPublished Oct 31, 2026 (UTC)SEC filing date Oct 30, 2026
Cboe Global MarketsCBOE$357.75+0.02%
CHD
The company said net sales for Q3 2026 rose 1.0% to $1,602 million, and organic sales grew 5.1%. It attributed the organic sales growth mainly to volume growth of 4.6% and higher price and product mix of 0.5%.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Church & DwightCHD$110.84+1.06%
BNY
The company said net income applicable to common shareholders for Q3 2026 was $1.6 billion ($2.34 per diluted common share), and excluding notable items it was $1.6 billion (Non-GAAP, $2.37 per diluted common share). Net income applicable to common shareholders for Q3 2025 was $1.3 billion ($1.88 per diluted common share).
US filing analysisUS10-Q · Quarterly reportPublished Oct 31, 2026 (UTC)SEC filing date Oct 30, 2026
BNY MellonBNY$141.24-2.48%
KVUE
The company said Net sales for the quarter ended September 27, 2026 rose 3.2% to $3.9 billion, an increase of $122 million from the prior-year period. Excluding the impact of 0.3% from changes in foreign currency exchange rates, Organic sales increased 2.9%, with volume up 1.6% and value realization up 1.3%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 31, 2026 (UTC)SEC filing date Oct 30, 2026
KenvueKVUE$19.310.00%
KVUE
The company said its net sales for Q3 2026 rose 3.2% from a year earlier. Organic sales grew 2.9%, and the foreign currency effect was 0.3%. The company cited volume growth of 1.6% and value realization of 1.3% as drivers of the organic sales increase.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
KenvueKVUE$19.310.00%
LYB
The company said net income for Q3 2026 was $758 million ($2.32 per diluted share), and excluding identified items it was $828 million ($2.54 per share). EBITDA was $1.4 billion, or $1.5 billion excluding identified items.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
LyondellBasellLYB$55.84-4.04%
VLO
The company said its wholly owned subsidiary Valero Refining-Texas, L.P. entered into a definitive agreement on October 29, 2026 to acquire all outstanding equity interests in LYB Houston Hub Holdings LLC from a LyondellBasell subsidiary, for a purchase price of $320.5 million, subject to closing adjustments.
US filing analysisUS8-K · Current reportPublished Oct 30, 2026 (UTC)SEC filing date Oct 30, 2026
Valero EnergyVLO$334.18-1.26%
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.